Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis☆
Daniel S. Reich(National Institutes of Health), Peter A. Calabresi(Johns Hopkins University), Kathleen M. Zackowski(Kennedy Krieger Institute), Eliza Gordon‐Lipkin(National Institutes of Health), Jonathan A.D. Farrell(Kennedy Krieger Institute), Susumu Mori(Johns Hopkins University), Craig Jones(Johns Hopkins University), Seth A. Smith(Vanderbilt University), Peter C.M. van Zijl(Kennedy Krieger Institute)
Cited by 94
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624